Compare AST SpaceMobile Inc (ASTS) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AST SpaceMobile Inc vs Novo Nordisk A/S — how do they compare? AST SpaceMobile Inc trades at $72.08 (market cap $20.54B), while Novo Nordisk A/S trades at $45.78 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 10.1× AST SpaceMobile Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while AST SpaceMobile Inc pays none. Which is the better fit depends on your goals.
| ASTS | NVO | |
|---|---|---|
Market Cap | $20.54B | $207.85B |
Sector | Media | Health |
52-Week High | $133.09 | $63.98 |
52-Week Low | $36.91 | $35.29 |
Enterprise Value | $21.25B | $222.55B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AST SpaceMobile Inc
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building the global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio. AST is on a mission to eliminate the connectivity gaps faced by mobile subscribers and finally bring broadband to the billions who remain unconnected.
Read more on ASTS →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
